Guardant Health Breast Cancer

Listing Websites about Guardant Health Breast Cancer

Filter Type:

Tests for Cancer Screening - GuardantHealth

(3 days ago) WebExplore Guardant Health's Shield™ blood test. Discover how our advanced technology detects cancer early, when it's most treatable. INVESTORS; CAREERS; Search Approach. in metastatic breast cancer: Results from plasmaMATCH trial [abstract]. In: …

https://guardanthealth.com/products/tests-for-cancer-screening/

Category:  Cancer Show Health

Home - GuardantHealth

(7 days ago) WebFrom using biomarkers to inform treatment in advanced cancer, to using circulating tumor DNA to not only assess response to treatment, but detect signs of remaining cancer and even identify the earliest signs of cancer, …

https://guardanthealth.com/

Category:  Cancer Show Health

Guardant Health to present data at San Antonio Breast Cancer …

(3 days ago) WebGuardant Health to present data at San Antonio Breast Cancer Symposium demonstrating utility of liquid biopsy in biomarker identification, therapy selection and …

https://www.businesswire.com/news/home/20231130360214/en/Guardant-Health-to-present-data-at-San-Antonio-Breast-Cancer-Symposium-demonstrating-utility-of-liquid-biopsy-in-biomarker-identification-therapy-selection-and-residual-disease-detection

Category:  Cancer Show Health

Guardant Health to present data at San Antonio Breast Cancer …

(8 days ago) WebPALO ALTO, Calif., November 30, 2023--Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, will present data showing the utility of liquid biopsy tests in …

https://finance.yahoo.com/news/guardant-health-present-data-san-130500087.html

Category:  Health Show Health

FDA Approves Blood Tests That Can Help Guide Cancer Treatment

(3 days ago) WebGuardant360 CDx, made by Guardant Health, was approved as a companion diagnostic for osimertinib (Tagrisso), a lung cancer therapy. FoundationOne …

https://www.cancer.gov/news-events/cancer-currents-blog/2020/fda-guardant-360-foundation-one-cancer-liquid-biopsy

Category:  Cancer Show Health

Guardant360 CDx Receives Companion Diagnostic - Cancer …

(4 days ago) WebGuardant 360 CDx has been approved by the FDA as a companion diagnostic for patients with ESR1-mutant, estrogen receptor (ER)–positive, HER2 …

https://www.cancernetwork.com/view/guardant360-cdx-receives-companion-diagnostic-designation-in-esr1-breast-cancer

Category:  Health Show Health

Guardant Health Presents Data Demonstrating Utility of …

(1 days ago) WebGuardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced it will present new data demonstrating the benefits of using the …

https://server1.guardanthealth.com/2021/12/06/guardant-health-presents-data-demonstrating-utility-of-comprehensive-genetic-profiling-with-guardant360-liquid-biopsy-test-to-guide-treatment-for-advanced-breast-cancer-patients-at-2021-san-anto/

Category:  Health Show Health

Liquid Biopsy Assay Expands Offerings to Include MRD, Disease

(8 days ago) WebThe Guardant Reveal assay has been expanded for the detection of minimal residual disease (MRD) and disease recurrence in patients with early-stage breast …

https://www.onclive.com/view/liquid-biopsy-assay-expands-offerings-to-include-mrd-disease-recurrence-detection-in-early-stage-breast-and-lung-cancer

Category:  Health Show Health

Guardant Health, Inc. - Guardant Health Announces Collaboration …

(7 days ago) WebThe Guardant Health oncology platform leverages capabilities to drive commercial adoption, improve patient clinical outcomes and lower healthcare costs …

https://investors.guardanthealth.com/press-releases/press-releases/2022/Guardant-Health-Announces-Collaboration-With-AstraZeneca-to-Develop-Companion-Diagnostic-to-Identify-Patients-With-ESR1-mutated-Metastatic-Breast-Cancer/default.aspx

Category:  Health Show Health

Guardant Reveal™: First Tissue-Free MRD Test for CRC

(7 days ago) WebAnnual Physician Notice. Advance Beneficiary Notice. Technical Information. Physician Insert. Guardant Reveal™ is the first tissue-free minimal residual disease (MRD) test for …

https://www.guardantcomplete.com/products/guardant-reveal

Category:  Health Show Health

Clinical Studies - GuardantHealth

(4 days ago) WebThe ECLIPSE study is a prospective registrational study to evaluate the performance of Guardant Health’s blood test in detecting signs of colorectal cancer compared to a …

https://guardanthealth.com/clinical-studies/

Category:  Cancer Show Health

Guardant Health to present real-world data supporting …

(Just Now) WebPALO ALTO, Calif., May 16, 2024--Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced it will present data from two real …

https://finance.yahoo.com/news/guardant-health-present-real-world-120500882.html

Category:  Health Show Health

Guardant Health Receives ‘Buy’ Rating on Strong Q1 Performance …

(Just Now) WebGuardant Health, Inc. is a precision oncology company, which engages in provision of precision oncology testing and development services. It focuses performing …

https://markets.businessinsider.com/news/stocks/guardant-health-receives-buy-rating-on-strong-q1-performance-and-positive-financial-outlook-1033371016

Category:  Health Show Health

Filter Type: